Placeholder image

List of Publications

  1. Datey A ,   Subburaj J,  Gopalan J,  Chakravortty D. 2017,Mechanism of transformation in Mycobacteria using a novel shockwave assisted technique driven by in situ generated oxyhydrogen, Sci Rep, doi:10.1038/s41598-017-08542-5
  2. Balakrishnan A,   Chakravortty D. 2017, Epithelial cell damage activates Bactericidal/permeability increasing-protein (BPI) expression in intestinal epithelium, Frontiers in Microbiol, doi: 10.3389/fmicb.2017.01567
  3. Mudakavi RJ, Vanamali S, Charkavortty D, Raichur A. 2017, Development of arginine based nanocarriers for targeting and treatment of intracellular Salmonella, RSC Advances, 12, 
  4. Balakrishnan A, Schnare M, Chakravortty D. 2016 Of men not mice: Bactericidal/permeability-increasing protein (BPI) expressed in human macrophages acts as a phagocytic receptor and modulates entry and replication of Gram-negative bacteria., Frontiers in Immunol. 7,455.
  5. Balakrishnan A, DasSarma P, Bhattacharjee O, Kim JM, DasSarma S, Chakravortty D. 2016, Halobacterial nano vesicles displaying murine bactericidal permeability-increasing protein rescue mice from lethal endotoxic shock., Sci Rep. Sep 20;6:33679.
  6. Mayuri Gogoi, Akshay Datey, Chakravortty D, 2016, Arginine transporters and its role in pathogenesis, Current Opinion in Microbiology, 29,43-48.
  7. Tiwary CS ,   Mudakavi RJ,   Kishore S,  Kashyap S,  Elumalai R,   Chakravortty D, Raichur AM,. Chattopadhyay K, 2016, Magnetic iron nanoparticles for in vivo targeted delivery and as biocompatible contrast agents, RSC Advances, DOI: 10.1039/C6RA14817D
  8. Garai P, Chandra K, Chakravortty D,2016, Bacterial peptide transporters: Messengers of nutrition to virulence., Virulence,1-13.
  9. Datey A, Thaha A, Patil S, Jagadeesh G, Chakravortty D, 2016, Enhancing the efficiency of desensitizing agents with shockwave treatment – A new paradigm in dentinal hypersensitivity management, RSC Advances, In press, DOI:101039/c6ra12342b
  10. Marathe SA, Balakrishnan A, Negi VD, Sakorey D, Chandra N, Chakravortty D,2016, Curcumin Reduces the Motility of Salmonella enterica serovar Typhimurium by Binding to the Flagella thereby Leading to Flagellar Fragility and Shedding. J Bacteriol. 198,1798-811
  11. DasSarma P, Negi VD, Balakrishnan A, Kim JM, Karan R, Chakravortty D, DasSarma S., Procedia Vaccinol. 2015;9:16-23
  12. Srinandan CS,  ElangoM, Gnanadhas DP,  Chakravortty D, 2015, Conflict and cooperation in Salmonella biofilm, Frontiers in Microbiology, 6,1468.
  13. Gnanadhas DP,   Elango M,  Datey A, Dipshikha Chakravortty,2015,Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy. Sci Rep ( NPG),  5,16043.
  14. Gnanadhas DP,  ElangoM, Janardhanraj S , Srinandan CS  , Strugnell RA,  Gopalan J,   Chakravortty D, 2015, Successful treatment of biofilm infections using shockwaves combined with antibiotic therapy, Sci Rep ( NPG),  5:17440.
  15. Gnanadhas DP,   Elango E,   Thomas MB,   Gopalan J ,   Chakravortty D,2015, Remotely triggered micro-shockwave responsive drug delivery system for resolving diabetic wound infection and controlling blood sugar levels, RSC Advances, 5, 13234-13238. 
  16. Chakraborty S, Gogoi M, Chakravortty D, 2015 , Lactoylglutathione lyase, a Critical Enzyme in Methylglyoxal Detoxification, Contributes to Survival of Salmonella in the Nutrient Rich Environment  Virulence, 6, 50-65. 
  17. Radhakrishnan K,  Gupta S, Gnanadhas DP, Datey A, Ramamurthy PC , Chakravortty D , Raichur AM, 2015,  Mesoporous Silica - Chondroitin Sulphate Hybrid Nanoparticles for Targeted and Bio-responsive Drug Delivery, New J Chemistry (RSC),  39, 1754 – 1760.  
  18. Garai P,   Lahiri A, Ghosh D,   Chatterjee J,   Chakravortty D, 2015, Peptide utilizing carbon starvation gene yjiY is required for flagella mediated infection caused by Salmonella,  Microbiology (SGM) ,
  19. Radhakrishnan K,  Thomas MB, Gnanadhas DP, Ramamurthy PC , Chakravortty D , Raichur AM, 2015,  Stimuli responsive protamine based biodegradable nanocapsules for enhanced bioavailability and intracellulardelivery of anticancer agents, J Nanopart Res., 17, 1-12
  20. P DasSarma, VD Negi, A Balakrishnan, JM Kim, R Karan, D Chakravortty , S DasSarma, 2015, Haloarchaeal gas vesicle nanoparticles displaying Salmonella antigen as a Novel approach to vaccine developement, Procedia in Vaccinology 9, 16-23 
  21. Chakraborty S, Chaudhuri D, Balakrishnan A, Chakravortty D, 2014, Salmonella methylglyoxal detoxification by STM3117 encoded Lactoylglutathione lyase affects virulence in Coordination with SPI-2 and Phagosomal acidification, Microbiology, 160,1999-2017.
  22. Chakraborty S, Karmakar K, Chakravortty D,2014, Cells producing their own nemesis: Understanding Methylglyoxal metabolism, IUBMB Life, 66,667-678.
  23. DasSarma P, Negi V, Balakrishnan A, Karan R, Barnes S, Ekulona F, Chakravortty  D**, DasSarma S**,2014, Haloarchaeal gas vesicle nanoparticles displaying Salmonella SopB antigen reduce bacterial burden when administered with live attenuated bacteria, Vaccine, (**equal corresponding author), 32,4543-4549.
  24. Radhakrishnan K,  Gupta S, Gnanadhas DP, Ramamurthy PC , ChakravorttyD , Raichur AM, 2014, Dual enzyme responsive and targeted nanocapsules for intracellular delivery of anticancer agents, RSC Advances, 4,45961-45968.
  25. Lahiri C, Pawar S, Sabarinathan R, Ashraf MI, Chand Y, Chakravortty D,2014,  Interactome analyses of Salmonella pathogenicity islands reveal SicA indispensable for virulence. J Theor Biol., 5193,461-5.
  26. Garai P, Gogoi M, Gopal G, Radhakrishnan Y, Nandakumar KS, Chakravortty D, 2014, The basics and advances of immunomodulators and antigen presentation-A key to development of potent memory response against pathogens, Expt Opin Therapeutic Biol, 14,1383-1397.
  27. Radhakrishnan K,  Gupta S, Gnanadhas DP, Ramamurthy PC ,   ChakravorttyD , and Raichur AM, 2014, Protamine-Capped Mesoporous Silica Nanoparticles for Biologically Triggered Drug Release, Part. Part. Syst. Charact.,31, 449–458.
  28. Gnanadhas DP,  Thomas MD , Thomas R, Raichur AM,  Chakravortty  D, 2013, Interaction of silver nanoparticles with serum proteins affects their antimicrobial activity in vivo, Antimicrob Agents Chemother,  57,4945-55.
  29. Gnanadhas DP,  Thomas MD ,   Elango M, Raichur AM,  Chakravortty D, 2013, Chitosan-Dextran sulfate nanocapsule drug delivery system as an effective therapeutic against Salmonella, an intraphagosomal pathogen, J Antimicrob Chemother,  68,2576-86.
  30. Marathe SA, Kumar R, Ajitkumar P, Nagaraja V, Chakravortty D, 2013, Curcumin reduces the antimicrobial activity of ciprofloxacin against Salmonella Typhimurium and Salmonella Typhi, J Antimicrob Chemother.,68,139-52.
  31. Eswarappa SM, Janice J, Balasundaram SV, Chakravortty D,2013,  Non-neutral evolution in non-LEE-encoded type III effectors of attaching and effacing Escherichia coli., Microbes Infect., 15,147-151.
  32. Thomas MB, Radhakrishnan K, Gnanadhas DP, Chakravortty D, Raichur AM, 2013, Intracellular delivery of doxorubicin encapsulated in novel pH-responsive chitosan/heparin nanocapsules. Int J Nanomedicine, 8:267-73.
  33. Mukherjee B, Mukhopadhyay R, Bannerjee B, Chowdhury S, Mukherjee S, Naskar K, Allam US, Chakravortty D, Sundar S, Dujardin JC, Roy S, 2013, Antimony-resistant but not antimony-sensitive Leishmania donovani up-regulates host IL-10 to overexpress multidrug-resistant protein 1. Proc Natl Acad Sci USA,110,E575-582.
  34. Gnanadhas DP, Marathe SA, Chakravortty D,2013,  Biocides - resistance, cross-resistance mechanisms and assessment. Expert Opin Investig Drugs, 22,191-206.
  35. Balakrishnan A, Marathe SA, Joglekar M, Chakravortty D, 2013, Bactericidal/permeability increasing protein: A multifaceted protein with functions beyond LPS neutralization. Innate Immun, 19,339-347.
  36. Marathe SA, Sen M, Dasgupta I, Chakravortty D, 2012, Differential modulation of intracellular survival of cytosolic and vacuolar pathogens by curcumin, Antimicrob Agents Chemother,56,5555-67.
  37. Rakesh SG, Gnanadhas DP, Allam US, Nataraja KN, Barhai PK, Jagadeesh G, Chakravortty D, 2012, Development of micro-shock wave assisted dry particle and fluid jet delivery system,  Appl Microbiol Biotechnol. ,96,647-52.
  38. Garai P, Gnanadhas DP, Chakravortty D,2012, Salmonella enterica serovars Typhimurium and Typhi as model organisms: Revealing  paradigm of host-pathogen interactions. Virulence, 3,  377-388.
  39. Marathe SA, Datey AA, Chakravortty D ,2012, Herbal Cocktail as Anti-infective: Promising Therapeutic for the Treatment of Viral Diseases. Recent Pat Antiinfect Drug Discov, 7,123-132.
  40. Allam US, Krishna MG, Sen M, Thomas R, Lahiri A, Gnanadhas DP, Chakravortty D, 2012,  Acidic pH induced STM1485 gene is essential for intracellular replication of Salmonella.Virulence, 3,1-14.
  41. Marathe SA, Chowdhury R, Bhattacharya R, Nagarajan AG, Chakravortty D, 2012, Direct detection of Salmonella without pre-enrichment in milk, ice-cream and fruit juice by PCR against hilA gene. Food Control, 23, 559-563.
  42. Marathe SA, Lahiri A, Negi VD, Chakravortty D, 2012, Typhoid fever & vaccine development: A partially answered question. Indian J Med Res, 135,161-169.
  43. Iyer N, Marathe SA, Chaudhari D,   Garai P, ChakravorttyD, 2012, Immunomodulation using agonists and antagonists: potential clinical applications. Expt Opin Invest drug, 21, 67-81.
  44. Shivakumar D, Lahiri C, Chakravortty D,2012, Computational studies on histidine kinase protein BaeS to target multidrug-resistant Salmonella, Med Chem Res, 22,1804-1811.
  45. Wiese M, Gerlach RG, Popp I, Matuszak J, Mahapatro M, Castiglione K, Chakravortty D, Willam C, Hensel M, Bogdan C, Jantsch J, 2012, Hypoxia-mediated impairment of the mitochondrial respiratory chain inhibits the bactericidal activity of macrophages. Infect Immun. 80, 1455-1466.
  46. Divya Prakash G, Anish RV, Jagadeesh G, Chakravortty D,2011, Bacterial transformation using micro-shock waves. Anal Biochem, 419, 292-301.
  47. Jagadeesh G, Prakash GD, Rakesh SG, Allam US, Krishna MG, Eswarappa SM, Chakravortty D,2011, Needleless vaccine delivery using micro-shock waves. Clin Vaccine Immunol, 4,539-45.
  48. Marathe SA, dasgupta I, Chakravortty D , 2011, Multifaceted roles of curcumin: two sides of a coin!,Expt Opin Therapeutic Biol, 11,1485-99.
  49. Garai P, Marathe SA, Chakravortty D, 2011, Effectors of Salmonella pathogenicity island 2: An island crucial to the life of Salmonella.Virulence, 2,177-80.
  50. Bansal K, Trinath J, Chakravortty D, Patil SA, Balaji KN, 2011, Pathogen-specific TLR2 protein activation programs macrophages to induce Wnt-beta-catenin signaling. J Biol Chem, 286, 37032-44.
  51. Chakravortty D, 2011, Water-free hand wash- How safe is our gut? Current Science,100,606.
  52. Lahiri A, Ananthalakshmi TK,   Nagarajan A, Ray S, Chakravortty D, 2011, TolA Mediates Differential Detergent Resistance Pattern between the Salmonella serovars Typhi and Typhimurium. Microbiology-SGM, 157, 1402-1415.
  53. Allam  US, Gopala KM,  Lahiri, A, Joy O, Chakravortty  D, 2011, Salmonella enterica serovar Typhimurium lacking hfq gene confers protective immunity against murine typhoid. PLoS ONE, 2, e16667.  
  54. Das P, Lahiri A, Lahiri A, Sen M, Iyer N, Kapoor N, Balaji KN, Chakravortty D, 2010, Cationic Amino Acid Transporters and Salmonella Typhimurium ArgT collectively Regulate Arginine availability towards Intracellular Salmonella Growth. PLoS ONE, 5, e15466.
  55. Lahiri A, Das P, Vani J, Shaila MS, Chakravortty D, 2010, TLR 9 activation in dendritic cells enhances salmonella killing and antigen presentation via involvement of the reactive oxygen species. PLoS One, 5, e13772.
  56. Eswarappa SM, Negi VD, Chakraborty S, Chandrasekhar Sagar BK,  Chakravortty D,2010, Division of the Salmonella-containing vacuole and depletion of acidic lysosomes in Salmonella-infected host cells are novel strategies of Salmonella enterica to avoid lysosomes. Infect Immun, 78, 68-79.
  57. Negi VD, Nagarajan AG, Chakravortty D, 2010, A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice. PLoS One, 5, e9139.
  58. Marathe SA, Ray S,Chakravortty D, 2010, Curcumin increases the pathogenicity of Salmonella enterica serovar Typhimurium in murine model. PLoS One, 5, e11511.
  59. Lahiri A, Eswarappa SM, Das P, Chakravortty D, 2010, Altering the balance between pathogen containing vacuoles and lysosomes: A lesson from Salmonella. Virulence, 1, 325-329.
  60. Lahiri A, Das P,Chakravortty D, 2010, New tricks new ways: Exploitation of a multifunctional enzyme arginase by pathogens. Virulence, 6, 1-3.
  61. Lahiri A, Iyer N, Das P, Chakravortty D,2010, Visiting the cell biology of Salmonella infection. Microbes Infect, 12, 809-818.
  62. Das P, Lahiri A, Chakravortty D,2010, Modulation of the arginase pathway in the context of microbial pathogenesis: a metabolic enzyme moonlighting as an immune modulator. PLoS Pathog, 6, e1000899.
  63. Chakravortty D, 2010, Salmonella Vaccine: A Black Sheep. Current Science, 98, 149-150.
  64. Nayak M, Kotian A, Marathe S, Chakravortty D, 2009, Detection of microorganisms using biosensors-a smarter way towards detection techniques. Biosens Bioelectron, 25, 661-667.
  65. Nagarajan AG, Karnam G, Lahiri A, Allam US, Chakravortty D,2009, Reliable means of diagnosis and serovar determination of blood-borne Salmonella strains: quick PCR amplification of unique genomic loci by novel primer sets. J Clin Microbiol, 47, 2435-2441.
  66. Nagarajan AG, Balasundaram SV, Janice J, Karnam G, Eswarappa  SM, Chakravortty D, 2009, SopB of Salmonella enterica serovar Typhimurium is a potential DNA vaccine candidate in conjugation with live attenuated bacteria. Vaccine, 27, 2804-2811.
  67. Marathe S, Negi VD, Chakravortty D,2009, Curcumin! Spicy panacea for all--friend or foe. Vaccine, 28, 291-292.
  68. Lahiri A, Das P, Chakravortty D,2009,Salmonella Typhimurium: insight into the multi-faceted role of the LysR-type transcriptional regulators in Salmonella. Int J Biochem Cell Biol, 41, 2129-2133.
  69. Eswarappa SM, Karnam G, Nagarajan AG, Chakraborty S, Chakravortty D, 2009, lac repressor is an antivirulence factor of Salmonella enterica: its role in the evolution of virulence in Salmonella. PLoS One, 4, e5789.
  70. Eswarappa SM, Janice J, Balasundaram SV, Dixit NM, Chakravortty D, 2009, Host-specificity of Salmonella enterica serovar Gallinarum: insights from comparative genomics. Infect Genet Evol, 9, 468-473.
  71. Das P, Lahiri A, Chakravortty D, 2009, Novel role of the nitrite transporter NirC in Salmonella pathogenesis: SPI2-dependent suppression of inducible nitric oxide synthase in activated macrophages. Microbiology, 155, 2476-2489.
  72. Sakure S, Negi VD, Mitra SK, Nandakumar KS,  Chakravortty D,2008, Vaccine with herbal adjuvant--a better cocktail to combat the infection. Vaccine, 26, 3387-3388.
  73. Lahiri A, Das P, Chakravortty D,2008, Arginase modulates Salmonella induced nitric oxide production in RAW264.7 macrophages and is required for Salmonella pathogenesis in mice model of infection. Microbes Infect, 10, 1166-1174.
  74. Lahiri A, Das P, Chakravortty D, 2008, The LysR-type transcriptional regulator Hrg counteracts phagocyte oxidative burst and imparts survival advantage to Salmonella enterica serovar Typhimurium. Microbiology, 154, 2837-2846.
  75. Lahiri A, Da, P, Chakravortty D,2008,Engagement of TLR signaling as adjuvant: towards smarter vaccine and beyond. Vaccine, 26, 6777-6783.
  76. Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, Volke M, Glasner J, Warnecke C, Wiesener MS. et al.,2008, Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol, 180, 4697-4705.
  77. Eswarappa SM, Pareek V,Chakravortty D,2008, Role of actin cytoskeleton in LPS-induced NF-kappaB activation and nitric oxide production in murine macrophages. Innate Immun, 14, 309-318.
  78. Eswarappa SM, Panguluri KK, Hensel M, Chakravortty D,2008, The yejABEF operon of Salmonella confers resistance to antimicrobial peptides and contributes to its virulence. Microbiology, 154, 666-678.
  79. Eswarappa SM, Janice J, Nagarajan AG, Balasundaram SV, Karnam G, Dixit NM, Chakravortty  D,2008,Differentially evolved genes of Salmonella pathogenicity islands: insights into the mechanism of host specificity in Salmonella. PLoS One, 3, e3829.
  80. Eswarappa SM, Basu N, Joy O,  Chakravortty  D, 2008, Folimycin (concanamycin A) inhibits LPS-induced nitric oxide production and reduces surface localization of TLR4 in murine macrophages. Innate Immun, 14, 13-24.
  81. Negi VD, Singhamahapatra S, Chakravortty D,2007, Salmonella enterica serovar Typhimurium strain lacking pmrG-HM-D provides excellent protection against salmonellosis in murine typhoid model. Vaccine, 25, 5315-5323.
  82. Chakravortty D, Rohde M, Jager L, Deiwick J,  Hensel M, 2005, Formation of a novel surface structure encoded by Salmonella Pathogenicity Island 2. EMBO J, 24, 2043-2052.
  83. Hansen-Wester I, Chakravortty D, Hensel M, 2004, Functional transfer of Salmonella pathogenicity island 2 to Salmonella bongori and Escherichia coli. Infect Immun, 72, 2879-2888.
  84. Cheminay C, Chakravortty D, Hensel  M,2004,Role of neutrophils in murine salmonellosis. Infect Immun, 72, 468-477.
  85. Jantsch J, Cheminay C, Chakravortty D, Lindig T, Hein J, Hensel M, 2003, Intracellular activities of Salmonella enterica in murine dendritic cells. Cell Microbiol, 5, 933-945.
  86. Chakravortty D, Hensel M, 2003, Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect, 5, 621-627.
  87. Chakravortty D,  Hensel M, 2002,Salmonella selectively stops traffic: response from Chakravortty and Hensel. Trends Microbiol, 10, 392-393.
  88. Chakravortty D, Hansen-Wester I, Hensel M, 2002, Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J Exp Med, 195, 1155-1166.
  89. Sugiyama T, Koide N, Chakravortty D, Kato Y, Mu MM, Yoshida T, Yokochi T,2001,The expression of membrane-bound CD14 renders mouse B-1 cells susceptible to LPS. J Endotoxin Res, 7, 223-226.
  90. Mu MM, Chakravortty D, Takahashi K, Kato Y, Sugiyama T, Koide N, Morikawa A, Yoshida T, Yokochi T, 2001, Production of experimental autoimmune sialadenitis in mice immunized with homologous salivary gland extract and Klebsiella O3 lipopolysaccharide. J Autoimmun, 16, 29-36.
  91. Mu MM, Chakravortty D, Sugiyama T, Koide N, Takahashi K, Mori I, Yoshida T, Yokochi T, 2001, The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells. J Endotoxin Res, 7, 431-438.
  92. Koide N, Sugiyama T, Kato Y, Chakravortty D, Mu MM, Yoshida T, Hamano T, Yokochi T, 2001, Mouse B1 cell line responds to lipopolysaccharide via membrane-bound CD14. J Endotoxin Res, 7, 39-43.
  93. Chakravortty D, KatoY, Sugiyama T, Koide N, Mu MM, Yoshida T, Yokochi T, 2001, Inhibition of p38 mitogen-activated protein kinase augments lipopolysaccharide-induced cell proliferation in CD14-expressing Chinese hamster ovary cells. Infect Immun, 69, 931-936.
  94. Chakravortty D, Kato Y, Sugiyama T, Koide N, Mu MM, Yoshida T, Yokochi T, 2001, The inhibitory action of sodium arsenite on lipopolysaccharide-induced nitric oxide production in RAW 267.4 macrophage cells: a role of Raf-1 in lipopolysaccharide signaling. J Immunol, 166, 2011-2017.
  95. Chakravortty D, Kato Y, Sugiyama T, Koide N, Mu MM, Yoshida T, Yokochi, T, 2001, Inhibition of caspase 3 abrogates lipopolysaccharide-induced nitric oxide production by preventing activation of NF-kappaB and c-Jun NH2-terminal kinase/stress-activated protein kinase in RAW 264.7 murine macrophage cells. Infect Immun, 69, 1315-1321.
  96. Morikawa A, Koide N, Kato Y, Sugiyama T, Chakravortty D, Yoshida T, Yokochi T,2000, Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun, 68, 6209-6214.
  97. Koide N, Kato Y, Sugiyama T, Chakravortty D, Mu MM, Yoshida T, Yokochi T, 2000, Exacerbation of vascular endothelial injury in the generalized Shwartzman reaction by the administration of anti-E-selectin antibody. Microbiol Immunol, 44, 197-200.
  98. Kato Y, Zhao M, Morikawa A, Sugiyama T, Chakravortty D, Koide N, Yoshida T, Tapping RI, Yang Y, Yokochi T. et al,2000,Big mitogen-activated kinase regulates multiple members of the MEF2 protein family. J Biol Chem, 275, 18534-18540.
  99. Chakravortty D, Nanda Kumar KS,2000,Bacterial lipopolysaccharide induces cytoskeletal rearrangement in small intestinal lamina propria fibroblasts: actin assembly is essential for lipopolysaccharide signaling. Biochim Biophys Acta, 1500, 125-136.
  100. Chakravortty D , Koide N, Kato Y, Sugiyama T, Mu MM, Yoshida T, Yokochi, T,2000,The inhibitory action of butyrate on lipopolysaccharide-induced nitric oxide production in RAW 264.7 murine macrophage cells. J Endotoxin Res, 6, 243-247.
  101. Chakravortty D, Koide N, Kato Y, Sugiyama T, Kawai M, Fukada M, Yoshida T, Yokochi T, 2000, Cytoskeletal alterations in lipopolysaccharide-induced bovine vascular endothelial cell injury and its prevention by sodium arsenite. Clin Diagn Lab Immunol, 7, 218-225.
  102. Chakravortty D, Kato Y, Koide  , Sugiyama T, Kawai M, Fukada M, Yoshida T, Yokochi,  T, 2000, Extracellular matrix components prevent lipopolysaccharide-induced bovine arterial endothelial cell injury by inhibiting p38 mitogen-activated protein kinase. Thromb Res, 98, 187-193.
  103. Morikawa  A , Kato Y , Sugiyama T, Koide N, Chakravortty D, Yoshida T, Yokochi, T,1999, Role of nitric oxide in lipopolysaccharide-induced hepatic injury in D-galactosamine-sensitized mice as an experimental endotoxic shock model. Infect Immun, 67, 1018-1024.
  104. Koide N, Narita K, Kato Y, Sugiyama T, Chakravortty D, Morikawa A, Yoshida T, Yokochi T,1999, Expression of Fas and Fas ligand on mouse renal tubular epithelial cells in the generalized shwartzman reaction and its relationship to apoptosis. Infect Immun, 67, 4112-4118.
  105. Chakravortty D, Kumar KS, 1999, Interaction of lipopolysaccharide with human small intestinal lamina propria fibroblasts favors neutrophil migration and peripheral blood mononuclear cell adhesion by the production of proinflammatory mediators and adhesion molecules. Biochim Biophys Acta, 1453, 261-272.
  106. Chakravortty D, Kumar KS, 1999, Modulation of barrier function of small intestinal epithelial cells by lamina propria fibroblasts in response to lipopolysaccharide: possible role in TNFalpha in inducing barrier dysfunction. Microbiol Immunol, 43, 527-533.
  107. Chakravortty D , Kato  Y , Koide  N , Sugiyama  T, Kawai M, Fukada, M, Yoshida T, Yokochi T, 1999, Production of tissue factor in CD14-expressing human umbilical vein endothelial cells by lipopolysaccharide. FEMS Microbiol Lett, 178, 235-239.
  108. Jiang GZ, Kato Y, Sugiyama, T, Koide N, Chakravortty D, Kawai M, Fukada M, Yoshida T,Yokochi T,1998,Role of CD86 (B7-2) in triggering of antigen-specific IgE antibody response by lipopolysaccharide. FEMS Immunol Med Microbiol, 21, 303-311.
  109. Chakravortty D, Nanda Kumar KS,1997,Microplate assay for detection of bacterial contamination in tissue culture media. Indian J Exp Biol, 35, 86-88.
  110. Chakravortty D, Kumar KS, 1997, Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide. Biochem Biophys Res Commun, 240, 458-463.